ACTA1 and chronic kidney disease: Immunoblotting results showed that the expression of FN, Col-I, and α-SMA, markers for fibrosis, was significantly upregulated in the CKD group, but losartan treatment decreased the expression of FN, Col-I, and α-SMA in 5/6 A/I rats (Figure 5B).